According to China Securities Regulatory Commission (CSRC), EASTROC(iron ii acetate solubility in water东鹏) Beverage (Group) Co., Ltd. (hereinafter refepil ferrous fumarate 210rred to as EASTROC) issued the Initialprenatal vit w fe fumarate Public Offering Prospectus (Declaration Draft), which is planned to beiron ferrous sulfate side effects listed with 1.49 billion yuan fundrpolydextrose iron complex vs ferrous fumarateaising on the Shanghai Stock Exchange. Over half of the fundraising will be used for its production base construction in cities in South and West of China[1].